Biotech

All Articles

Lundbeck slashes worth of $250M Abide acquistion after pain drawback

.Lundbeck is reducing guide market value of its own $250 thousand Abide Therapeutics purchase in act...

Real- World Data Fulfills Clinical Trial Design: Maximizing Procedures and Web Site Option

.The assimilation of real-world information (RWD) in to process expediency and also site collection ...

Where are they right now? Overtaking past Fierce 15 honorees

.At this year's Ferocious Biotech Top in Boston ma, our experts overtook innovators in the biotech i...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is actually setting down $30 thousand ahead of time to purchase Yale spinout Modifi ...

Radiopharma Alpha-9 elevates $175M series C to fund clinical press

.Alpha-9 Oncology has raised a $175 million series C round to stake its own clinical-stage radiophar...

Ocuphire to completely transform into gene treatment biotech through Opus buyout

.Eye drug manufacturer Ocuphire Pharma is acquiring genetics therapy designer Piece Genes in an all-...

Roche culls hack candidate, pivots KRAS system in Q3 upgrade

.Roche's chronic coughing course has faltered to a halt. The drugmaker, which axed the plan after th...

Merck- Gilead long-acting dental combination reduces HIV for 48 full weeks

.Gilead Sciences and Merck &amp Co. have guided their once-weekly HIV mix therapy past another landm...

Lykos approves FDA look at that MDMA approval depends on new test

.Lykos Therapeutics may have dropped three-quarters of its team following the FDA's rejection of its...

Septerna plans $158M IPO to cash readouts for GPCR pipeline

.Septerna may be actually yet to disclose "any type of relevant professional records," yet the biote...